Color Code
Light Blue

EmPOWERED Health Program

Learn more by visiting empoweredhealth.org

1071
Rachna Chandora, MPH
Chronic Disease & Birth Defects
Cancer
Chronic Diseases
Off
EmPOWERED Health Program
CDC's National Center for Chronic Disease Prevention and Health Promotion
Amgen Inc.
United States of America
/give
To improve cancer outcomes by educating and empowering people to become proactive participants in their own health and improve patient:physician conversations and shared decision making.
Hide Title
Off
Hide Teaser
Off
Hide Partners
Off
Hide Program Location
Off
Hide Program Initiative
Off
Hide Program Type
Off
Hide Tags
Off
Cancer

Monitoring E-Cigarette Use Among Youth

Study Shows Positive Result of New Restrictions on Flavored Tobacco Products

A Foundation-led study presented at the 2024 Society for Research on Nicotine and Tobacco annual meeting found that monthly e-cigarette sales in California declined by 41% after statewide restrictions on the sale of flavored tobacco products took effect. However, the report also noted that the tobacco industry continues to market products to offset these declines, including non-menthol cigarettes that contain other cooling chemicals. Continuing to monitor flavored tobacco product sales is key to assessing policies like these and informing further policy development and implementation.

Monitoring U.S. E-Cigarette Sales: National and State Trends

Since being introduced to the U.S. market in 2007, e-cigarette use among youth has increased to epidemic levels (Surgeon General's Advisory on E-cigarette Use Among Youth, 2018). The availability of flavored e-cigarettes is one of the most commonly cited reasons for e-cigarette use among youth (Tsai et al., 2018). Given the importance of flavors contributing to use of e-cigarettes among youth, these data briefs build on this previously published article, providing an update on trends in unit sales of e-cigarettes in the U.S. by product and flavor type. These retail sales data briefs are intended to provide information about population trends in sales for participating retailers; they do not include online sales or vape store sales and cannot be used to make conclusions about subgroup purchasing or behaviors. These estimates are based on the information available at the time of publication and may be subject to updates as more information becomes available.

National E-Cigarette Data Briefs

Issue 27 (data through 12/31/2023)
data brief, aggregate data

Issue 26 (data through 9/10/2023)
data brief, aggregate data

Issue 25 (data through 6/18/2023)
data brief, aggregate data

Issue 24 (data through 3/26/2023)
data brief, aggregate data

Issue 23 (data through 12/25/2022)
data brief, aggregate data

Issue 22 (data through 10/30/2022)
data brief, aggregate data

Issue 21 (data through 7/10/2022)
data brief, aggregate data

Issue 20 (data through 4/17/2022)
data brief, aggregate data

Issue 19 (data through 3/20/2022)
data brief, aggregate data

Issue 18 (data through 2/20/2022)
data brief, aggregate data

Issue 17 (data through 1/23/2022)
data brief, aggregate data

Issue 16 (data through 12/26/2021)
data brief, aggregate data

Issue 15 (data through 11/28/2021)
data brief, aggregate data

Issue 14 (data through 10/31/2021)
data brief, aggregate data

Issue 13 (data through 10/3/2021)
data brief, aggregate data

Issue 12 (data through 9/5/2021)
data brief, aggregate data

Issue 11 (data through 8/8/2021)
data brief, aggregate data

Issue 10 (data through 7/11/2021; updated 10/28/21)
data brief, aggregate data

Issue 09 (data through 6/13/2021)
data brief, aggregate data

Issue 08 (data through 5/16/2021; updated 8/23/21)
data brief, aggregate data

Issue 07 (data through 4/18/2021)
data brief, aggregate data

Issue 06 (data through 3/21/2021; updated 6/25/21)
data brief, aggregate data

Issue 05 (data through 2/21/2021; updated 6/25/21)
data brief, aggregate data

Issue 04 (data through 1/24/2021; updated 6/25/21)
data brief, aggregate data

Issue 03 (data through 12/27/2020)
data brief, aggregate data

Issue 02 (data through 11/29/2020)
data brief, aggregate data

Issue 01 (data through 10/4/2020)
data brief, aggregate data

State E-Cigarette Data Briefs

Issue 12 (data through 12/31/2023)
data brief, aggregate data

Issue 11 (data through 9/10/2023)
data brief, aggregate data

Issue 10 (data through 6/18/2023)
data brief, aggregate data

Issue 09 (data through 3/26/2023)
data brief, aggregate data

Issue 08 (data through 12/25/2022)
data brief, aggregate data

Issue 07 (data through 10/30/2022; updated 1/1/23)
data brief, aggregate data

Issue 06 (data through 3/20/2022)
data brief, aggregate data

Issue 05 (data through 12/26/2021)
data brief, aggregate data

Issue 04 (data through 9/5/2021)
data brief, aggregate data

Issue 03 (data through 6/13/2021)
data brief, aggregate data

Issue 02 (data through 3/21/2021; updated 7/30/21)
data brief, aggregate data

Issue 01 (data through 12/27/2020; updated 7/30/21)
data brief, aggregate data

Supporting Documents

Methods

FAQ

Monitoring U.S. Cigarette Sales

The monitoring of other tobacco product sales in conjunction with the monitoring of e-cigarette sales is necessary to provide a comprehensive picture of the overall U.S. tobacco product market. These cigarette data briefs provide estimates of cigarette sales in the U.S. market overall and select U.S. states. These retail sales data briefs are intended to provide information about population trends in cigarette sales for participating retailers; they do not include online sales or tobacco specialty store sales and cannot be used to make conclusions about subgroup purchasing or behaviors. These estimates are based on the information available at the time of publication and may be subject to updates as more information becomes available.

National and State Cigarette Briefs

Issue 02 (data through 12/31/23)
data brief, aggregate data

Issue 01 (data through 10/08/23; updated 1/18/24)
data brief, aggregate data

chart icon

In 2023, 309.4 million units of e-cigarette products were sold in U.S. retail stores nationwide. This is a decrease of 5.3% from 2022.
 

Flavored e-cigarette icon

During 2022-2023, unit sales of tobacco flavored e-cigarettes decreased by 11.8% (65.0 to 57.3 million units), while sales of other flavors such as menthol, mint, clear/other cooling, fruit or candy, decreased by 4.3% (260.3 to 249.1 million units). 

e-cigarette icon

The market share of disposable e-cigarette products increased from 52.0% to 57.8% between 2022 and 2023. Among disposable e-cigarette products, those with flavors other than tobacco accounted for 94.7% of the market in 2023.

1063
Elizabeth Seaman PhD, MHS
Chronic Disease & Birth Defects
Tobacco Control
Chronic Diseases
Off
Monitoring E-Cigarette Use Among Youth
CDC's National Center for Chronic Disease Prevention and Health Promotion
Bloomberg Philanthropies
United States of America
/give
To generate scientifically defensible and rapidly available data to assess the effectiveness of e-cigarette flavor restriction policies, the Monitoring the E-cigarette Use Among Youth in Select U.S. Cities and States program has been underway since 2019 with program activities that include: 1) analyzing retail sales data for e-cigarettes and other tobacco products and 2) implementing surveys to collect timely estimates of e-cigarette use and related behaviors among youth and young adults.
Hide Title
Off
Hide Teaser
Off
Hide Partners
Off
Hide Program Location
Off
Hide Program Initiative
Off
Hide Program Type
Off
Hide Tags
Off

Newborn Screening Test for Spinal Muscular Atrophy

1026
Rachna Chandora, MPH
Chronic Disease & Birth Defects
Maternal and Child Health
Newborn screening
Off
Newborn Screening Test for Spinal Muscular Atrophy
CDC's Division of Laboratory Sciences
Biogen MA Inc.
United States of America
/give
To facilitate collaborative development of a newborn bloodspot screening test to detect the genetic lesions that cause spinal muscular atrophy. The test will be designed to use in public health newborn screening laboratories.
Birth Defects

Preventing Mother-to-Child Transmission of HIV and HBV

679
Chronic Disease & Birth Defects
Maternal and Child Health
pregnant woman
Off
Preventing Mother-to-Child Transmission of HIV
CDC's National Center for Chronic Disease Prevention and Health Promotion
Gilead Sciences, Inc.
China
/give
To help CDC increase understanding of the effectiveness of using maternal tenofovir containing combination drug during the second and third trimesters of pregnancy for the prevention of mother-to-child transmission of HIV and HBV in co-infected mothers.
Gilead Sciences, Inc.
CDC's National Center for Chronic Disease Prevention and Health Promotion
HIV
Pregnancy

Building U.S. Capacity to Review and Prevent Maternal Deaths

According to CDC, about 700 women die each year in the United States as a result of pregnancy or delivery complications.

Related Media Articles

Building U.S. Capacity to Review and Prevent Maternal Deaths promotes the maternal mortality review process as the best way to understand why maternal mortality in the United States is increasing, and identify interventions to prevent maternal deaths. It supports essential review functions and enables data to be combined across jurisdictions for national learning, which was not previously possible. The initiative is a collaboration between the CDC Foundation, the Centers for Disease Control and Prevention (CDC) and the Association of Maternal and Child Health Programs (AMCHP). Funding for the collaboration was provided through an award agreement with Merck on behalf of its Merck for Mothers program.

Learn more about this program in the new 2018 Report From Nine Maternal Mortality Review Committees. The data used in this report is made possible by a partnership with nine states: Colorado, Delaware, Georgia, Hawaii, Illinois, North Carolina, Ohio, South Carolina, and Utah, who have been supporting the development of the Maternal Mortality Review Information Application (MMRIA). The 2017 Report from Maternal Mortality Review Committees: A View Into Their Critical Role is also available. Additional resources that support maternal mortality review committees are available at the Review to Action website.

RTA logo

                    MMRIA

 

896
Chronic Disease & Birth Defects
Women's Health
pregnant woman
Off
Building U.S. Capacity to Review and Prevent Maternal Deaths
CDC's National Center for Chronic Disease Prevention and Health Promotion
United States of America
/give
To increase the United States' capacity to use data for preventing maternal mortality.
Merck for Mothers
CDC's National Center on Birth Defects and Developmental Disabilities
Maternal Health

Sickle Cell Data Collection (SCDC) Program

855
Rebecca Cook, MPH
Chronic Disease & Birth Defects
Sickle Cell
sickle cell disease
Off
Sickle Cell Data Collection (SCDC) Program
California and Georgia, USA
CDC's National Center on Birth Defects and Developmental Disabilities
Pfizer Inc.
Sanofi
Global Blood Therapeutics, Inc.
Doris Duke Charitable Foundation
United States of America
/give
To build the framework for collecting data about individuals in the United States with sickle cell disease in order to monitor their health outcomes, evaluate current systems of care, and inform the development of a comprehensive care model to meet the needs of these individuals throughout their life.
Biogen; Pfizer Inc.; Global Blood Therapeutics
CDC’s National Center on Birth Defects and Developmental Disabilities
Hide Title
Off
Hide Teaser
Off
Hide Partners
Off
Hide Program Location
Off
Hide Program Initiative
Off
Hide Program Type
Off
Hide Tags
Off
Birth Defects

Healthy People Law and Health Policy Project

994
Sekou Sidibe, MPH
Chronic Disease & Birth Defects
Population Health
chronic
Off
Healthy People Law and Health Policy Project
CDC's National Center for Chronic Disease Prevention and Health Promotion
Robert Wood Johnson Foundation
United States of America
/give
To collaborate with the Healthy People Initiative (a science-based, 10-year national objective for improving the health of Americans) to demonstrate the value of legal and policy interventions in improving Americans’ health.
Robert Wood Johnson Foundation
CDC's National Center for Chronic Disease Prevention and Health Promotion
Subscribe to Chronic Disease & Birth Defects